K2 Asset Management Holdings Ltd (ASX:KAM)

Ligand Pharmaceuticals Revenue

K2 Asset Management Holdings had revenue of 2.87M AUD in the half year ending December 31, 2024, with 186.49% growth. This brings the company's revenue in the last twelve months to 5.40M, up 45.90% year-over-year. In the fiscal year ending June 30, 2024, K2 Asset Management Holdings had annual revenue of 5.25M with 165.61% growth.

• Revenue (ttm): 5.40M
• Revenue Growth: +45.90%
• P/S Ratio: 3.13
• Revenue / Employee: 269.91K
• Employees: 20
• Market Cap: 16.88M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	5.25M	3.28M	165.61%
Jun 30, 2023	1.98M	-143.03K	-6.74%
Jun 30, 2022	2.12M	-2.10M	-49.74%
Jun 30, 2021	4.22M	1.07M	34.15%
Jun 30, 2020	3.15M	-1.65M	-34.43%